FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$4.69 B | $5.02 B | $5.58 B | $6.13 B | $6.52 B | $6.76 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$837.00 M | $753.10 M | $828.60 M | $850.30 M | $907.00 M | $923.30 M |
Gross Profit Revenue minus cost of revenue. |
|
$3.85 B | $4.27 B | $4.75 B | $5.28 B | $5.61 B | $5.84 B |
|
Operating Expense
Costs to run business. 
|
|
$1.21 B | $1.25 B | $1.31 B | $1.35 B | $1.38 B | $1.40 B |
Operating Income Profit from operations. |
|
$2.65 B | $3.02 B | $3.44 B | $3.93 B | $4.23 B | $4.43 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$166.90 M | -$162.70 M | -$159.40 M | -$160.90 M | -$129.70 M | $1.65 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$895.30 M | -$637.10 M | -$877.30 M | -$770.80 M | -$1.22 B | -$1.04 B |
Total Other Income (Net) Net non-operating items. |
|
$728.40 M | $474.40 M | $717.90 M | $609.90 M | $1.10 B | $1.17 B |
Income Before Tax Profit before taxes. |
|
$3.37 B | $3.49 B | $4.15 B | $4.54 B | $5.33 B | $5.60 B |
Income Tax Expense Taxes on income. |
|
$736.70 M | $799.30 M | $927.40 M | $1.02 B | $1.27 B | $1.34 B |
|
Net Income
Final profit.
|
|
$2.64 B | $2.69 B | $3.23 B | $3.53 B | $4.04 B | $4.24 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$7.30 | $7.41 | $8.87 | $9.69 | $11.18 | $11.80 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$7.29 | $7.40 | $8.86 | $9.67 | $11.16 | $11.72 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
358.34 M | 358.71 M | 359.02 M | 359.39 M | 359.63 M | 359.32 M |
Diluted Average Shares Outst. Shares including dilution. |
|
358.93 M | 359.18 M | 359.50 M | 359.94 M | 360.23 M | 363.21 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$3.54 B | $3.65 B | $4.31 B | $4.70 B | $5.45 B | $5.47 B |
EBITDA Earnings before interest, tax, D&A. |
|
$3.93 B | $4.02 B | $4.67 B | $5.04 B | $5.72 B | $5.69 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$385.40 M | $362.60 M | $352.60 M | $336.80 M | $275.00 M | $219.70 M |
| Company Report |
FY 2025
CME Group's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
CME Group's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
CME Group's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
CME Group's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
